MedTrace Logo

Evaluate the Efficacy and Safety of Lidocaine-Containing Hyaluronic Acid Filler in the Treatment of Nasolabial Folds.

NCT05040594 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-09-10

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy and safety of PavéDerm J-fill soft dermal filler vs. Restylane® Lyft lidocaine in the treatment of moderate to severe nasolabial folds.

Conditions

  • Wrinkles Such as Nasolabial Folds

Interventions

DEVICE

PavéDerm J-Fill Soft Dermal Filler

Sodium Hyaluronate 20 mg with Lidocaine hydrochloride 3 mg/mL

DEVICE

Restylane® Lyft Lidocaine

Sodium Hyaluronate 20 mg with Lidocaine hydrochloride 3 mg/mL

Sponsors & Collaborators

  • Yung Shin Pharm. Ind. Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Chen Chih-Chiang, Ph.D. · Taipei Veterans General Hospital, Taiwan

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-12-26
Primary Completion
2020-10-15
Completion
2020-11-05

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05040594 on ClinicalTrials.gov